Skip to main content
Clinical Trials/CTRI/2024/08/072599
CTRI/2024/08/072599
Not yet recruiting
未知

A retrospective analysis of adherence rate and associated factors in a Tenofovir, Lamivudine, and Dolutegravir based regimen in People Living with HIV - NI

Government Medical College, Patiala0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: B20- Human immunodeficiency virus [HIV]disease
Sponsor
Government Medical College, Patiala
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients above the age of 18 years
  • 2\) Patients diagnosed with HIV
  • 3\) PLHIV registered at ART Centre in Government Medical College and Rajindra Hospital, Patiala
  • 4\) Treatment naïve PLHIV initiated on Tenofovir 300 mg, Lamivudine 300 mg, Dolutegravir 50 mg, fixed\-dose combination regimen
  • 5\) PLHIV on TLD with a minimum of 2 drug refills irrespective of follow\-up period

Exclusion Criteria

  • 1\) Records with incomplete data on ART adherence
  • 2\) PLHIV not on Tenofovir 300 mg, Lamivudine 300 mg, Dolutegravir 50 mg, fixed\-dose combination regimen
  • 3\) PLHIV whose ART regimen was switched during the study period

Outcomes

Primary Outcomes

Not specified

Similar Trials